These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 17951021)

  • 1. Smoking cessation treatment in community-based substance abuse rehabilitation programs.
    Reid MS; Fallon B; Sonne S; Flammino F; Nunes EV; Jiang H; Kourniotis E; Lima J; Brady R; Burgess C; Arfken C; Pihlgren E; Giordano L; Starosta A; Robinson J; Rotrosen J
    J Subst Abuse Treat; 2008 Jul; 35(1):68-77. PubMed ID: 17951021
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Smoking cessation treatment among patients in community-based substance abuse rehabilitation programs: exploring predictors of outcome as clues toward treatment improvement.
    Reid MS; Jiang H; Fallon B; Sonne S; Rinaldi P; Turrigiano E; Arfken C; Robinson J; Rotrosen J; Nunes EV
    Am J Drug Alcohol Abuse; 2011 Sep; 37(5):472-8. PubMed ID: 21854292
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Varying nicotine patch dose and type of smoking cessation counseling.
    Jorenby DE; Smith SS; Fiore MC; Hurt RD; Offord KP; Croghan IT; Hays JT; Lewis SF; Baker TB
    JAMA; 1995 Nov; 274(17):1347-52. PubMed ID: 7563558
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predicting smoking cessation. Who will quit with and without the nicotine patch.
    Kenford SL; Fiore MC; Jorenby DE; Smith SS; Wetter D; Baker TB
    JAMA; 1994 Feb; 271(8):589-94. PubMed ID: 8301790
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluating Nicotine Craving, Withdrawal, and Substance Use as Mediators of Smoking Cessation in Cocaine- and Methamphetamine-Dependent Patients.
    Magee JC; Lewis DF; Winhusen T
    Nicotine Tob Res; 2016 May; 18(5):1196-201. PubMed ID: 26048168
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Randomized Clinical Trial of Nicotine Preloading for Smoking Cessation in People with Posttraumatic Stress Disorder.
    Dedert EA; Dennis PA; Calhoun PS; Dennis MF; Beckham JC
    J Dual Diagn; 2018; 14(3):148-157. PubMed ID: 29693495
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of varenicline versus transdermal nicotine replacement therapy on cigarette demand on quit day in individuals with substance use disorders.
    Murphy CM; MacKillop J; Martin RA; Tidey JW; Colby SM; Rohsenow DJ
    Psychopharmacology (Berl); 2017 Aug; 234(16):2443-2452. PubMed ID: 28500373
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of Nicotine Patch vs Varenicline vs Combination Nicotine Replacement Therapy on Smoking Cessation at 26 Weeks: A Randomized Clinical Trial.
    Baker TB; Piper ME; Stein JH; Smith SS; Bolt DM; Fraser DL; Fiore MC
    JAMA; 2016 Jan; 315(4):371-9. PubMed ID: 26813210
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of pre-treatment with nicotine patch on withdrawal symptoms and abstinence rates in smokers subsequently quitting with the nicotine patch: a randomized controlled trial.
    Schuurmans MM; Diacon AH; van Biljon X; Bolliger CT
    Addiction; 2004 May; 99(5):634-40. PubMed ID: 15078238
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized trial of concurrent smoking-cessation and substance use disorder treatment in stimulant-dependent smokers.
    Winhusen TM; Brigham GS; Kropp F; Lindblad R; Gardin JG; Penn P; Hodgkins C; Kelly TM; Douaihy A; McCann M; Love LD; DeGravelles E; Bachrach K; Sonne SC; Hiott B; Haynes L; Sharma G; Lewis DF; VanVeldhuisen P; Theobald J; Ghitza U
    J Clin Psychiatry; 2014 Apr; 75(4):336-43. PubMed ID: 24345356
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of nicotine lozenges on affective smoking withdrawal symptoms: secondary analysis of a randomized, double-blind, placebo-controlled clinical trial.
    Shiffman S
    Clin Ther; 2008 Aug; 30(8):1461-75. PubMed ID: 18803988
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The nicotine patch in smoking cessation. A randomized trial with telephone counseling.
    Westman EC; Levin ED; Rose JE
    Arch Intern Med; 1993 Aug; 153(16):1917-23. PubMed ID: 8250653
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nicotine patches used in combination with e-cigarettes (with and without nicotine) for smoking cessation: a pragmatic, randomised trial.
    Walker N; Parag V; Verbiest M; Laking G; Laugesen M; Bullen C
    Lancet Respir Med; 2020 Jan; 8(1):54-64. PubMed ID: 31515173
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transdermal nicotine for smoking cessation. Six-month results from two multicenter controlled clinical trials. Transdermal Nicotine Study Group.
    JAMA; 1991 Dec; 266(22):3133-8. PubMed ID: 1956099
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nicotine patch therapy for smoking cessation combined with physician advice and nurse follow-up. One-year outcome and percentage of nicotine replacement.
    Hurt RD; Dale LC; Fredrickson PA; Caldwell CC; Lee GA; Offord KP; Lauger GG; Marŭsić Z; Neese LW; Lundberg TG
    JAMA; 1994 Feb; 271(8):595-600. PubMed ID: 8301791
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transdermal nicotine therapy and primary care. Importance of counseling, demographic, and participant selection factors on 1-year quit rates. The Nebraska Primary Practice Smoking Cessation Trial Group.
    Daughton D; Susman J; Sitorius M; Belenky S; Millatmal T; Nowak R; Patil K; Rennard SI
    Arch Fam Med; 1998; 7(5):425-30. PubMed ID: 9755734
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The transdermal nicotine patch: results of a randomised placebo-controlled trial.
    Richmond RL; Harris K; de Almeida Neto A
    Med J Aust; 1994 Jul; 161(2):130-5. PubMed ID: 8028537
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mecamylamine combined with nicotine skin patch facilitates smoking cessation beyond nicotine patch treatment alone.
    Rose JE; Behm FM; Westman EC; Levin ED; Stein RM; Ripka GV
    Clin Pharmacol Ther; 1994 Jul; 56(1):86-99. PubMed ID: 8033499
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Varenicline versus transdermal nicotine patch for smoking cessation: results from a randomised open-label trial.
    Aubin HJ; Bobak A; Britton JR; Oncken C; Billing CB; Gong J; Williams KE; Reeves KR
    Thorax; 2008 Aug; 63(8):717-24. PubMed ID: 18263663
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Varenicline versus nicotine patch with brief advice for smokers with substance use disorders with or without depression: effects on smoking, substance use and depressive symptoms.
    Rohsenow DJ; Tidey JW; Martin RA; Colby SM; Swift RM; Leggio L; Monti PM
    Addiction; 2017 Oct; 112(10):1808-1820. PubMed ID: 28498504
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.